Captura Biopharma

Little Rock, United States

Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.

$50.0M raised

Aug 2021

Venture - Series Unknown

Biopharma Biotechnology Life Science

Top Investors

The Global Emerging Markets Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Captura Biopharma

How much funding has Captura Biopharma raised?

Captura Biopharma has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2021.

Who are Captura Biopharma's investors?

Captura Biopharma's investors include The Global Emerging Markets Group.

Where is Captura Biopharma headquartered?

Captura Biopharma is headquartered in Little Rock, United States.

What does Captura Biopharma do?

Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.

What stage is Captura Biopharma at?

Captura Biopharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 18, 2021.

MLA

"Captura Biopharma — Funding & Investors." VCBacked, August 18, 2021, https://www.vcbacked.co/company/captura-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2021). Captura Biopharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/captura-biopharma

Wikipedia (cite web)

{{cite web |title=Captura Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/captura-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 18, 2021.